Skip to main
CYRX

CryoPort (CYRX) Stock Forecast & Price Target

CryoPort (CYRX) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CryoPort is a trusted partner for biotechnology and pharmaceutical companies, providing temperature-controlled logistics and storage solutions for the life sciences industry. With a focus on supporting the growing cell and gene therapy market, CryoPort is well-positioned to benefit from the increasing demand for these therapies. The company's expanding customer base, strong pipeline of clinical trials, and strategic acquisitions and partnerships, position them to continue delivering strong revenue growth and expanding margins. Risks include clinical trial setbacks for their customers, potential competition in the logistics market, and macroeconomic pressures. However, with increasing revenue visibility and a strong balance sheet, CryoPort's stock has the potential for continued growth and improvement in profitability.

Bears say

CryoPort is a company focused on providing integrated, temperature-controlled supply chain solutions for the life sciences industry, with a particular emphasis on the cell and gene therapy market. While the company has a strong customer base and has experienced growth in both its Life Sciences Services segment and its Life Sciences Products segment, there are potential risks and challenges on the horizon that could affect its future revenue growth and profitability. These include potential delays in cell and gene therapy approvals, competition from other logistics providers, and potential saturation in the market. These factors, combined with the company's high valuation, lead to a negative outlook on CryoPort's stock.

CryoPort (CYRX) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 83% of analysts recommend a Strong Buy, 17% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CryoPort and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CryoPort (CYRX) Forecast

Analysts have given CryoPort (CYRX) a Strong Buy based on their latest research and market trends.

According to 6 analysts, CryoPort (CYRX) has a Strong Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CryoPort (CYRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.